Urology · Bellefontaine, OH
NPI
1982603668
Since 2005
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2160 Ewing Crawfis Cir
Bellefontaine, OH, 43311
Phone (937) 593-0070
Groups this clinician bills Medicare through
Medicare paid, 2024
$160K
2,585 services
Medicare patients, 2024
718
Average age 75
Drug cost, 2024
$151K
2,474 prescriptions
Company payments, 2025
$18.85
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Roger G Amigo was code 99213 (office e&m - established), 747 times for 519 patients. In total Roger G Amigo billed 2,585 services in 50 codes, and Medicare paid $160K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-11-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 747 | 519 | $57.99 | $43K |
| 51798 Ultrasound - Nonspecific | Office | 557 | 431 | $6.82 | $3,800 |
| 99214 Office E&M - Established | Office | 286 | 229 | $78.39 | $22K |
| 81003 Clinical Chemistry | Office | 222 | 149 | $2.19 | $486 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 181 | 21 | $138.07 | $25K |
| 52000 Cystourethroscopy | Office | 118 | 96 | $158.77 | $19K |
| 51702 Other Organ Systems | Office | 89 | 21 | $41.82 | $3,722 |
| 99212 Office E&M - Established | Office | 72 | 66 | $35.50 | $2,556 |
| 96402 Chemotherapy Administration | Office | 61 | 21 | $23.71 | $1,446 |
| 99203 Office E&M - New | Office | 32 | 32 | $68.36 | $2,188 |
| 51705 Other Organ Systems | Office | 29 | 11 | $68.81 | $1,995 |
| 99211 Office E&M - Established | Office | 24 | 19 | $14.29 | $343 |
| 52310 Calculus Removal - Urinary | Office | 19 | 17 | $219.39 | $4,168 |
| 52356 Calculus Removal - Urinary | Facility | 18 | 17 | $307.11 | $5,528 |
| 55700 Other Organ Systems | Facility | 16 | 16 | $74.95 | $1,199 |
By year: 2022 $164K for 2,745 services; 2023 $157K for 2,547 services; 2024 $160K for 2,585 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 222 | 149 | $2.19 | $486 |
Medicare prescription drug claims, 2024
In 2024, the drug Roger G Amigo prescribed most often to Medicare patients was Tamsulosin Hcl, with 533 prescriptions and refills. In total Roger G Amigo wrote 2,474 Medicare prescriptions that cost $151K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 533 | 1,452 | 168 | $7,274 |
| Finasteride Generic | 440 | 1,199 | 130 | $5,727 |
| Oxybutynin Chloride Generic | 239 | 470 | 70 | $3,587 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 135 | 253 | 43 | $2,913 |
| Myrbetriq Mirabegron | 127 | 180 | 26 | $78K |
| Solifenacin Succinate Generic | 113 | 209 | 32 | $8,020 |
| Ciprofloxacin Hcl Generic | 96 | 157 | 66 | $594 |
| Tolterodine Tartrate Generic | 69 | 123 | 19 | $7,340 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 59 | 59 | 49 | $313 |
| Testosterone Cypionate Generic | 53 | 100 | 11 | $3,211 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 52 | 119 | 28 | $2,903 |
| Cephalexin Generic | 49 | 109 | 24 | $326 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 46 | 89 | 18 | $226 |
| Bethanechol Chloride Generic | 36 | 76 | 12 | $2,234 |
| Testosterone Generic | 35 | 35 | Under 11 | $2,379 |
Brand drugs: - claims; generic drugs: 2,296 claims; opioid claims: 59.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Roger G Amigo $18.85 ($18.85 in general payments such as food, travel and fees) from 1 company. The largest payer was Tolmar, Inc. with $18.85.
| Company | Payments | Amount |
|---|---|---|
| Tolmar, Inc. | 1 | $18.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.